Author

Louis James Maher III

Observed names: L J Maher, L James Maher, L. JAMES MAHER, L. James Maher, L. James Maher III, L. James Maher, III, L. Maher, L.James Maher, LJ Maher, Louis J Maher, III, Louis J. Maher, Louis J. Maher III, Louis James Maher, Louis Jim Maher, Louis J Maher, L James Maher, Maher, Louis J.

Institutions: Mayo Clinic, University of Michigan

Observed institutions: California Institute of Technology, Nebraska Medical Center, Mayo Clinic, Howard Hughes Medical Institute, University of Michigan, University of Nebraska Medical Center, University of Maryland, College Park, University of California, Berkeley

ORCID: 0000-0002-5043-6422

Observed ORCID: 0000-0002-5043-6422

OpenAlex ID: A5046386274

Analysis of promoter-specific repression by triple-helical DNA complexes in a eukaryotic cell-free transcription system

1992 · L. James Maher, Peter B. Dervan, et al. · Biochemistry · 162

Prospects for the Therapeutic Use of Antigene Oligonucleotides

1996 · L. James Maher · Cancer Investigation · 90

DNA triple‐helix formation: An approach to artificial gene repressors?

1992 · L. James Maher · BioEssays · 85

Effects of nucleoid proteins on DNA repression loop formation in Escherichia coli

2007 · Nicole A. Becker, Jason D. Kahn, et al. · Nucleic Acids Research · 75

Exclusion of RNA strands from a purine motif triple helix

1994 · Craig L. Semerad, L. James Maher · Nucleic Acids Research · 68

Inhibition of T7 RNA polymerase initiation by triple-helical DNA complexes: a model for artificial gene repression

1992 · L. James Maher · Biochemistry · 64

Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis

2012 · Branislav Nastasijevic, Brent R. Wright, et al. · PLoS ONE · 60

Mechanism of promoter repression by Lac repressor–DNA loops

2012 · Nicole A. Becker, Justin P. Peters, et al. · Nucleic Acids Research · 59

Gene repression by minimal lac loops in vivo

2010 · Laura M. Bond, Justin P. Peters, et al. · Nucleic Acids Research · 58

In Vivo Recognition of an RNA Aptamer by Its Transcription Factor Target

2001 · Laura A. Cassiday, L. James Maher · Biochemistry · 58

Repression of bacteriophage promoters by DNA and RNA oligonucleotides

1993 · John U. Skoog, L. James Maher · Nucleic Acids Research · 32

Quantitative Methods for Measuring DNA Flexibility In Vitro and In Vivo

2010 · Justin P. Peters, Nicole A. Becker, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 30

Aptamers in neuro-oncology: An emerging therapeutic modality

2023 · Caroline Doherty, Brandon Wilbanks, et al. · Neuro-Oncology · 29

Ion-dependent conformational switching by a DNA aptamer that induces remyelination in a mouse model of multiple sclerosis

2012 · John Smestad, L. James Maher · Nucleic Acids Research · 27

High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma

2013 · Irina Bancos, John Paul Bida, et al. · PLoS ONE · 25

Oligonucleotide-Directed DNA Triple-Helix Formation: An Approach to Artificial Repressors?

1991 · L. JAMES MAHER, BARBARA WOLD, et al. · Antisense Research and Development · 25

A conditional mouse model of complex II deficiency manifesting as Leigh‐like syndrome

2019 · Fatimah Al Khazal, Molly Nelson Holte, et al. · The FASEB Journal · 24

DNA constraints on transcription activation in Vitro

2000 · Eric D Ross, Anne M Keating, et al. · Journal of Molecular Biology · 21

Sequence-specific binding of DNA and RNA to immobilized Nickel ions

2008 · Branislav Nastasijevic, Nicole A. Becker, et al. · Biochemical and Biophysical Research Communications · 20

Functional Studies of Potential Intrastrand Triplex Elements in the Escherichia coli Genome

2002 · Paula Rodrigues Hoyne, L.James Maher · Journal of Molecular Biology · 20

Unexpected obesity, rather than tumorigenesis, in a conditional mouse model of mitochondrial complex II deficiency

2020 · Fatimah Al Khazal, Seungwoo Kang, et al. · The FASEB Journal · 18

Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy

2019 · Brandon Wilbanks, John Smestad, et al. · Nucleic Acid Therapeutics · 18

A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?

2018 · Maria K. Perwein, John A. Smestad, et al. · Expert Opinion on Biological Therapy · 18

Glial cells as therapeutic targets in progressive multiple sclerosis

2019 · Brandon Wilbanks, LJ Maher, et al. · Expert Review of Neurotherapeutics · 17

DNA bending by asymmetrically tethered cations: influence of tether flexibility

2001 · Philip R Hardwidge, Dong-Kye Lee, et al. · Chemistry & Biology · 17

Works count: 114

Citation count: 1,307

H-index: 20

I10-index: 32